INSY
Insys Therapeutics, Inc.
INSY
INSY
Delisted
INSY was delisted on the 18th of June, 2019.
99 hedge funds and large institutions have $372M invested in Insys Therapeutics, Inc. in 2014 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 36 increasing their positions, 35 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
15% more funds holding
Funds holding: 86 → 99 (+13)
3% more repeat investments, than reductions
Existing positions increased: 36 | Existing positions reduced: 35
Holders
99
Holding in Top 10
3
Calls
$4.81M
Puts
$2.13M
Top Buyers
| 1 | +$44.3M | |
| 2 | +$28M | |
| 3 | +$11.9M | |
| 4 |
Renaissance Technologies
New York
|
+$5.68M |
| 5 |
TCM
Tamarack Capital Management
Carlsbad,
California
|
+$5.16M |
Top Sellers
| 1 | -$13.9M | |
| 2 | -$10.1M | |
| 3 | -$7.69M | |
| 4 |
BIM
Bogle Investment Management
Newton Lower Falls,
Massachusetts
|
-$7.59M |
| 5 |
EMFAT
Emerald Mutual Fund Advisers Trust
Leola,
Pennsylvania
|
-$6.09M |